£197m Payments Made Under New UK Pricing Scheme But Access Promises Still To Materialize

Payments have now been made under the UK’s 2019 pricing and access to branded medicines scheme, but industry will have to wait longer for promises on access to materialize.

money coins surrounded by pills tablets and capsules - Image
The new drug pricing scheme is expected to save the UK money. • Source: Shutterstock

More from Pricing Debate

More from Market Access